US Pharma MarketingBiopharma moves to reduce development risk earlier than ever
The biopharma operating model has shifted. Tighter capital, higher expectations and evolving regulatory frameworks are reshaping drug development strategy. Parexel leaders explain how companies are adapting.
Tighter capital, higher expectations and evolving regulatory frameworks are reshaping drug development strategy. Parexel leaders explain how companies are adapting.
Source: FierceBiotech